CH
About D-innovation
Founded in 2007, D-innovation Pharmaceutical Co., Ltd. is a high-tech enterprise dedicated to supplying high-quality pharmaceutical intermediates and APIs as well as providing efficient customized R & D and production services for globally.
Our R & D center is located in Tianfu Life Science Park of Chengdu High-tech Zone, and our production site is located in "West Medicine Valley" of Meishan City, Sichuan Province.
The company has won the titles of "National Specialized, Special and New Small Giant Enterprise", "National High-tech Enterprise", "Sichuan Gazelle Enterprise", and has passed ISO and GMP system certification, and is expected to pass FDA certification in 2025.
-
R&D Center -
Test base -
Production base
-
EHS system -
R&D system -
Production system -
Quality system
Process Safety: DSC, RC1, ARC Process Risk Classification Assessment
Environmental protection: committed to replacing the source of the process end and reducing the process consumption; classified collection in the production process and effective treatment at the end
Occupational Health: OEB Risk Grading Management and Control System
R & D platform: continuous flow platform, chiral separation platform, preparative separation platform, metal catalysis platform
R & D contents: process route design, development and optimization; analytical method development and validation; impurity confirmation and preparation; stability study; CMC document compilation.
DCS full-automatic control
High and low temperature reaction
Multifunctional production cell
20-10000 L flexible reaction system
GMP clean area
50 + Quality Personnel
Five times to improve the quality system of professional institutions
Strictly follow GMP & ICH quality system
Quality management team 20 + years of experience, 50 + customer quality audit/year, 100% pass
Chengdu D-innovation Pharmaceutical Co.,Ltd (R & D) was founded
Sichuan D-innovation Pharmaceutical Technology Co., Ltd. (Production base) was founded;
Meishan factory was built
the second batch of science and technology projects in Chengdu
Meishan Plant Phase I is completed and put into use
Meishan plant passed ISO quality and environmental safety system certification
Meishan plant obtained drug production license (GMP system)
Passed Chinese GMP inspection; Submitted the first FDA API application
The first API CDE to "A" was approved/the second FDA API variety application was submitted
Chengdu Innovis Pharma Co., Ltd.
To become a first-class pharmaceutical raw material enterprise
customer first, Effort Basis, innovation rooted, excellence aspiration
to protect human health and create maximum value for customers
